Multihance

MultiHance^®, the highest relaxivity gadolinium-based contrast agent (GBCA) approved for MRI of the CNS and whole body, delivers significantly better contrast enhancement in diagnostic imaging of CNS lesions and other pathologies compared to other MRI agents available in the market.

Multihance has an additional feature of being the only MRI contrast available in the market, which is excreted through the Hepatobiliary route in addition to the renal route.

• Multihance contains Gadobenate Dimeglumine (Gd Bopta)
• Available in 10ml, 15ml & 20ml packs.
• Multihance is US FDA Approved.